Pancreatic cancer remains one of the most devastating diagnoses a patient can receive, with survival rates that have barely improved in decades and a prognosis that often leaves little room for hope. Among the various forms of this disease, pancreatic ductal adenocarcinoma (PDAC) stands out as the
In an era where antibiotic resistance threatens global health, claiming millions of lives annually due to untreatable infections, a groundbreaking approach is emerging from the intersection of ancient wisdom and modern science, offering hope against this escalating crisis. Herb-based bioprocessing,
What if the key to unlocking life-saving treatments for diseases like cancer lies not in creating new drugs, but in perfecting how they reach their target? Every year, countless promising therapies fail due to poor delivery mechanisms, leaving patients and researchers grappling with unmet needs. At
Imagine a condition so rare yet so devastating that it drives an insatiable hunger, challenging both patients and medical science to find relief, while Prader-Willi syndrome, a genetic disorder affecting a small but deeply impacted population, has long awaited effective treatments for its hallmark
Imagine a world where the arduous process of developing life-saving drugs, which often spans over a decade and costs billions of dollars, is dramatically shortened and made more cost-effective through cutting-edge technology. This vision is becoming increasingly tangible as artificial intelligence
I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the industry. Today, we’ll dive into the critical intersection of cancer research, advocacy, and policy, exploring
